Quarterly ResultJul 22, 2026, 04:01 AM
Genenta-backed Sòphia HT FY2025 Sales +29.3%; EBITDA +68.1%
AI Summary
Genenta Science S.p.A. announced strong financial results for its investee, Sòphia High Tech S.r.l., for the fiscal year ended December 31, 2025. Sòphia HT reported a 29.3% increase in sales to €7.17 million and a 68.1% rise in EBITDA to €1.61 million, driven by higher sales, increased operating income, and disciplined cost management. Genenta, which owns approximately 19% of Sòphia HT, is evolving into Saentra Forge, focusing on aerospace, defense, biotech, and national security technologies. Sòphia HT also appointed a new Board of Directors to guide its industrial scale-up and international expansion.
Key Highlights
- Sòphia HT FY2025 sales rose 29.3% to €7.17 million.
- Sòphia HT total value of production increased 34.7% to €8.47 million.
- Sòphia HT EBITDA grew 68.1% to €1.61 million, with margin expanding to 19.0%.
- Sòphia HT operating profit advanced 80.8% to €1.21 million.
- Genenta Science is evolving into Saentra Forge, a strategic industrial consolidator.
- Genenta Science currently owns approximately 19% of Sòphia HT.
- Sòphia HT appointed a new Board of Directors for its next growth phase.
Price Impact
More from GNTA